Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Llama peripheral B-cell populations producing conventional and heavy chain-only IgG subtypes are phenotypically indistinguishable but immunogenetically distinct.

Henry KA, van Faassen H, Harcus D, Marcil A, Hill JJ, Muyldermans S, MacKenzie CR.

Immunogenetics. 2019 Apr;71(4):307-320. doi: 10.1007/s00251-018-01102-9. Epub 2019 Jan 18.

PMID:
30656359
2.

Deletion of a Yci1 Domain Protein of Candida albicans Allows Homothallic Mating in MTL Heterozygous Cells.

Sun Y, Gadoury C, Hirakawa MP, Bennett RJ, Harcus D, Marcil A, Whiteway M.

MBio. 2016 Apr 26;7(2):e00465-16. doi: 10.1128/mBio.00465-16.

3.

Comparative xylose metabolism among the Ascomycetes C. albicans, S. stipitis and S. cerevisiae.

Harcus D, Dignard D, Lépine G, Askew C, Raymond M, Whiteway M, Wu C.

PLoS One. 2013 Nov 13;8(11):e80733. doi: 10.1371/journal.pone.0080733. eCollection 2013.

4.

Structurally unique interaction of RBD-like and PH domains is crucial for yeast pheromone signaling.

Yerko V, Sulea T, Ekiel I, Harcus D, Baardsnes J, Cygler M, Whiteway M, Wu C.

Mol Biol Cell. 2013 Feb;24(3):409-20. doi: 10.1091/mbc.E12-07-0516. Epub 2012 Dec 14.

5.

Reverse genetics in Candida albicans predicts ARF cycling is essential for drug resistance and virulence.

Epp E, Vanier G, Harcus D, Lee AY, Jansen G, Hallett M, Sheppard DC, Thomas DY, Munro CA, Mullick A, Whiteway M.

PLoS Pathog. 2010 Feb 5;6(2):e1000753. doi: 10.1371/journal.ppat.1000753.

6.

Chemogenomic profiling predicts antifungal synergies.

Jansen G, Lee AY, Epp E, Fredette A, Surprenant J, Harcus D, Scott M, Tan E, Nishimura T, Whiteway M, Hallett M, Thomas DY.

Mol Syst Biol. 2009;5:338. doi: 10.1038/msb.2009.95. Epub 2009 Dec 22.

7.

Binding the atypical RA domain of Ste50p to the unfolded Opy2p cytoplasmic tail is essential for the high-osmolarity glycerol pathway.

Ekiel I, Sulea T, Jansen G, Kowalik M, Minailiuc O, Cheng J, Harcus D, Cygler M, Whiteway M, Wu C.

Mol Biol Cell. 2009 Dec;20(24):5117-26. doi: 10.1091/mbc.E09-07-0645.

8.

Transcript profiling of a MAP kinase pathway in C. albicans.

Huang H, Harcus D, Whiteway M.

Microbiol Res. 2008;163(4):380-93. doi: 10.1016/j.micres.2008.03.001. Epub 2008 May 8.

9.

A human-curated annotation of the Candida albicans genome.

Braun BR, van Het Hoog M, d'Enfert C, Martchenko M, Dungan J, Kuo A, Inglis DO, Uhl MA, Hogues H, Berriman M, Lorenz M, Levitin A, Oberholzer U, Bachewich C, Harcus D, Marcil A, Dignard D, Iouk T, Zito R, Frangeul L, Tekaia F, Rutherford K, Wang E, Munro CA, Bates S, Gow NA, Hoyer LL, Köhler G, Morschhäuser J, Newport G, Znaidi S, Raymond M, Turcotte B, Sherlock G, Costanzo M, Ihmels J, Berman J, Sanglard D, Agabian N, Mitchell AP, Johnson AD, Whiteway M, Nantel A.

PLoS Genet. 2005 Jul;1(1):36-57. Epub 2005 Jun 17.

10.

Transcription profiling of cyclic AMP signaling in Candida albicans.

Harcus D, Nantel A, Marcil A, Rigby T, Whiteway M.

Mol Biol Cell. 2004 Oct;15(10):4490-9. Epub 2004 Jul 21.

11.

Superoxide dismutases in Candida albicans: transcriptional regulation and functional characterization of the hyphal-induced SOD5 gene.

Martchenko M, Alarco AM, Harcus D, Whiteway M.

Mol Biol Cell. 2004 Feb;15(2):456-67. Epub 2003 Nov 14.

12.

CDC42 is required for polarized growth in human pathogen Candida albicans.

Ushinsky SC, Harcus D, Ash J, Dignard D, Marcil A, Morchhauser J, Thomas DY, Whiteway M, Leberer E.

Eukaryot Cell. 2002 Feb;1(1):95-104.

13.

Transcription profiling of Candida albicans cells undergoing the yeast-to-hyphal transition.

Nantel A, Dignard D, Bachewich C, Harcus D, Marcil A, Bouin AP, Sensen CW, Hogues H, van het Hoog M, Gordon P, Rigby T, Benoit F, Tessier DC, Thomas DY, Whiteway M.

Mol Biol Cell. 2002 Oct;13(10):3452-65.

14.
15.

Ras links cellular morphogenesis to virulence by regulation of the MAP kinase and cAMP signalling pathways in the pathogenic fungus Candida albicans.

Leberer E, Harcus D, Dignard D, Johnson L, Ushinsky S, Thomas DY, Schröppel K.

Mol Microbiol. 2001 Nov;42(3):673-87.

16.

Signaling through adenylyl cyclase is essential for hyphal growth and virulence in the pathogenic fungus Candida albicans.

Rocha CR, Schröppel K, Harcus D, Marcil A, Dignard D, Taylor BN, Thomas DY, Whiteway M, Leberer E.

Mol Biol Cell. 2001 Nov;12(11):3631-43.

17.

Mitogen-activated protein kinase-defective Candida albicans is avirulent in a novel model of localized murine candidiasis.

Guhad FA, Jensen HE, Aalbaek B, Csank C, Mohamed O, Harcus D, Thomas DY, Whiteway M, Hau J.

FEMS Microbiol Lett. 1998 Sep 1;166(1):135-9.

18.

Roles of the Candida albicans mitogen-activated protein kinase homolog, Cek1p, in hyphal development and systemic candidiasis.

Csank C, Schröppel K, Leberer E, Harcus D, Mohamed O, Meloche S, Thomas DY, Whiteway M.

Infect Immun. 1998 Jun;66(6):2713-21.

19.

Virulence and hyphal formation of Candida albicans require the Ste20p-like protein kinase CaCla4p.

Leberer E, Ziegelbauer K, Schmidt A, Harcus D, Dignard D, Ash J, Johnson L, Thomas DY.

Curr Biol. 1997 Aug 1;7(8):539-46.

20.

Signal transduction through homologs of the Ste20p and Ste7p protein kinases can trigger hyphal formation in the pathogenic fungus Candida albicans.

Leberer E, Harcus D, Broadbent ID, Clark KL, Dignard D, Ziegelbauer K, Schmidt A, Gow NA, Brown AJ, Thomas DY.

Proc Natl Acad Sci U S A. 1996 Nov 12;93(23):13217-22.

21.
22.
23.

Cloning of Saccharomyces cerevisiae STE5 as a suppressor of a Ste20 protein kinase mutant: structural and functional similarity of Ste5 to Far1.

Leberer E, Dignard D, Harcus D, Hougan L, Whiteway M, Thomas DY.

Mol Gen Genet. 1993 Nov;241(3-4):241-54.

PMID:
8246877
24.
25.

RTA, a candidate G protein-coupled receptor: cloning, sequencing, and tissue distribution.

Ross PC, Figler RA, Corjay MH, Barber CM, Adam N, Harcus DR, Lynch KR.

Proc Natl Acad Sci U S A. 1990 Apr;87(8):3052-6.

26.

Lymphokine transcription in vascularized mouse heart grafts: effects of "tolerance" induction.

Lowry RP, Wang K, Vernooij B, Harcus D.

Transplant Proc. 1989 Feb;21(1 Pt 1):72-3. No abstract available.

PMID:
2468227
27.
28.

In defence of administration for group practice.

Harcus DS.

Health Bull (Edinb). 1972 Oct;30(4):259-62. No abstract available.

PMID:
5079040

Supplemental Content

Loading ...
Support Center